This video series is provided by Ascendis Pharma in support of Growth Awareness Week 2019. Thank you to the families who courageously shared their stories. All interviews were conducted voluntarily in July 2019 without instruction or compensation. The views of the participants do not necessarily reflect the views of Ascendis Pharma. Please consult a healthcare professional if you have questions about growth disorders and their signs or symptoms.
Committed to Making a Difference in the Lives of Patients
Ascendis Pharma is applying its innovative TransConTM technologies to build a leading, fully integrated biopharmaceutical company focused on making a meaningful difference in patients’ lives. Guided by our core values of patients, science and passion, we utilize our technology platform to create new and potentially best-in-class therapies. We currently have a pipeline of three independent, rare disease endocrinology product candidates in clinical development. We have also established oncology as our second therapeutic area of focus.
ACHieve Study Underway
ACHieve is a natural history study designed to gain insight into the experience of children with achondroplasia. Learn More
TransCon Technology Platform
Learn how we’re using our innovative TransCon technology (short from “transient conjugation”) to create best-in-class products to address unmet patient needs. Watch Video